<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05070065</url>
  </required_header>
  <id_info>
    <org_study_id>Prot. PG/2020/7577</org_study_id>
    <nct_id>NCT05070065</nct_id>
  </id_info>
  <brief_title>Virtual Reality VAlidation Tool for Cognitive Rehabilitation, Oriented Project for People With Psychosocial Disabilieties</brief_title>
  <official_title>VIVA-CORE! Virtual Reality VAlidation Tool for Cognitive Rehabilitation, a REcovery Oriented Project for People With Psychosocial Disabilieties: Protocol of Randomize Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cagliari</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Cagliari</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized controlled open-label cross-over clinical feasibility study with waiting list, 60&#xD;
      people will be recruited from the Consultation and Psychosomatic Psychiatry Center of the&#xD;
      University Hospital of Cagliari (San Giovanni di Dio Civil Hospital) with a diagnosis of&#xD;
      mental disorder. The investigators propose a VR intervention of 3 months with 2 weekly&#xD;
      session of CEREBRUM (cognitive remedy intervention with virtual reality) first to the group A&#xD;
      and then to the group B.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Cognitive remedial interventions have been found to be effective in the treatment&#xD;
      of various psycho-social disorders. The use of Virtual reality as a rehabilitation tool has&#xD;
      been showing various scientific evidences in recent years like in cardiovascular,&#xD;
      neurological and musculoskeletal rehabilitation. In mental health evidence they seem to be&#xD;
      concentrated in the rehabilitation of social cognition in people with schizophrenia diagnosis&#xD;
      and psychotherapy. The aim of this study is to evaluate the feasibility and the effectiveness&#xD;
      of the first Cognitive Remedial toll in Virtual Reality (CEREBRUM) for people that has&#xD;
      experienced in mental health.&#xD;
&#xD;
      Methods: Randomized controlled open-label cross-over clinical feasibility study with waiting&#xD;
      list, 60 people will be recruited from the Consultation and Psychosomatic Psychiatry Center&#xD;
      of the University Hospital of Cagliari (San Giovanni di Dio Civil Hospital) with a diagnosis&#xD;
      of mental disorder. The investigators propose a intervention of 3 months with 2 weekly&#xD;
      session of CEREBRUM first to the group A and then to the group B&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">November 10, 2021</start_date>
  <completion_date type="Anticipated">November 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Randomized controlled open-label cross-over clinical feasibility study with waiting list</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>people with psychosocial disabilities</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Memory</measure>
    <time_frame>All measure at: T0 (base line) -T1 (at 3 months from baseline) -T2 (at 6 months from baseline) -T3 (at 12 months from baseline)</time_frame>
    <description>Rey's Figure Test Word's Figure Test Digit Span Forward and Backward Test Test of the Tale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Monitoring Side effects of Virtual Reality</measure>
    <time_frame>During the first VR session - At 1 month (after 8 sessions) - T1 (at 3 months from baseline)</time_frame>
    <description>Questionnaire (Qualitative)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Attention</measure>
    <time_frame>All measure at: T0 (base line) -T1 (at 3 months from baseline) -T2 (at 6 months from baseline) -T3 (at 12 months from baseline)</time_frame>
    <description>Matrix Test Digit Symbol Substitution Test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Executive functions</measure>
    <time_frame>All measure at: T0 (base line) -T1 (at 3 months from baseline) -T2 (at 6 months from baseline) -T3 (at 12 months from baseline)</time_frame>
    <description>Trial Making Test Verbal Phonological and Semantic Fluency Test Cognitive Estimation Test - CET Stroop Test Frontal Assessment Battery - FAB</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>All measure at: T0 (base line) -T1 (at 3 months from baseline) -T2 (at 6 months from baseline) -T3 (at 12 months from baseline)</time_frame>
    <description>Short Form Healthy Survey Questionnaire - SF-12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alexithymia</measure>
    <time_frame>All measure at: T0 (base line) -T1 (at 3 months from baseline) -T2 (at 6 months from baseline) -T3 (at 12 months from baseline)</time_frame>
    <description>Toronto Alexithymia Scale - TAS-20</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety</measure>
    <time_frame>All measure at: T0 (base line) -T1 (at 3 months from baseline) -T2 (at 6 months from baseline) -T3 (at 12 months from baseline)</time_frame>
    <description>Self Anxiety Rating Scale - SAS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>All measure at: T0 (base line) -T1 (at 3 months from baseline) -T2 (at 6 months from baseline) -T3 (at 12 months from baseline)</time_frame>
    <description>The Patient Health Questionnaire - PHQ-9</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biological Rythms</measure>
    <time_frame>All measure at: T0 (base line) -T1 (at 3 months from baseline) -T2 (at 6 months from baseline) -T3 (at 12 months from baseline)</time_frame>
    <description>Biological Rythms Interview of Assesment in Neuropsychiatry - BRIAN</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General and social functioning</measure>
    <time_frame>All measure at: T0 (base line) -T1 (at 3 months from baseline) -T2 (at 6 months from baseline) -T3 (at 12 months from baseline)</time_frame>
    <description>Health of the Nation Outcome Scales - HoNOS</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Mood Disorders</condition>
  <arm_group>
    <arm_group_label>virtual reality</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The experimental group A receives the cognitive remedy intervention with virtual reality (CEREBRUM)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>waiting list</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>waiting list</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cognitive remedy intervention with virtual reality (CEREBRUM)</intervention_name>
    <description>Cognitive Remedial method Virtual Reality (CEREBRUM)</description>
    <arm_group_label>virtual reality</arm_group_label>
    <arm_group_label>waiting list</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age from 18 to 75;&#xD;
&#xD;
          -  Diagnosis of psychosis and / or mood disorder according to DSM-IV (American&#xD;
             Psychiatric Association, 2000).&#xD;
&#xD;
          -  both sexes;&#xD;
&#xD;
          -  users who sign the informed consent;&#xD;
&#xD;
          -  users under protection for which the informed consent is signed by the guardian&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The non-satisfaction of the inclusion criteria;&#xD;
&#xD;
          -  The diagnosis of epilepsy or serious eye diseases, due to the risk associated with the&#xD;
             excessive stimulation of virtual reality&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alessandra Perra, Phd student</last_name>
    <phone>+393481444501</phone>
    <email>alessandra.perra93@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>P.O. San Giovanni di Dio, AOU Cagliari</name>
      <address>
        <city>Cagliari</city>
        <zip>09100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mauro Carta, MD</last_name>
      <phone>070 6093498</phone>
      <phone_ext>0039</phone_ext>
      <email>maurogcarta@gmail.com; mgcarta@tiscali.it</email>
    </contact>
    <investigator>
      <last_name>Giorgia Testa</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 21, 2021</study_first_submitted>
  <study_first_submitted_qc>September 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 6, 2021</study_first_posted>
  <last_update_submitted>October 25, 2021</last_update_submitted>
  <last_update_submitted_qc>October 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cagliari</investigator_affiliation>
    <investigator_full_name>Mauro Giovanni Carta</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Virtual Reality</keyword>
  <keyword>Remediation</keyword>
  <keyword>Mental Health</keyword>
  <keyword>Recovery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mood Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

